Trending Topics

Loading trending topics...

See what’s trending right now
5 hours ago

Families relying on SNAP and Medicaid brace for GOP-led cuts as polls show many believe these programs are underfunded, while hospices weigh in on the contentious assisted dying debate.

'My cancer was dismissed as a pulled muscle'

BBC NewsMonday, June 16, 2025 at 5:38:57 AM
'My cancer was dismissed as a pulled muscle'
Former footballer Mel Tottoh endured months of rib and back pain that doctors initially brushed off as a pulled muscle—only to later discover he had myeloma, a type of blood cancer. His story highlights the dangers of misdiagnosis and the need for persistent advocacy when something feels seriously wrong.
Editor’s Note: Tottoh’s experience isn’t just a personal ordeal—it’s a stark reminder of how easily serious conditions can be overlooked, especially when symptoms mimic common injuries. For anyone dealing with persistent pain, his story underscores the importance of pushing for answers, even when you’re told it’s "nothing serious." It also raises broader questions about how healthcare systems handle vague or hard-to-diagnose symptoms.
— Curated via WP Now’s

Was this article worth reading? Share it

Latest from Health
Norma Swenson, ‘Our Bodies, Ourselves’ Co-Author, Dies at 93
neutralHealth
Norma Swenson, a pioneering co-author of Our Bodies, Ourselves—the groundbreaking book that demystified women’s health and empowered generations—has passed away at 93. A fierce advocate for natural childbirth and bodily autonomy, she helped transform a grassroots project into a global phenomenon that challenged taboos and gave women the tools to take control of their health.
Higher doses of Zepbound to be offered on Eli Lilly website
neutralHealth
Eli Lilly is expanding access to higher doses of its weight-loss drug Zepbound, making the 12.5 mg and 15 mg options available for direct purchase on its website at $499 per month. This move targets self-paying patients who may struggle to secure prescriptions or insurance coverage for these doses.
Editor’s Note: For people relying on Zepbound for weight management, this could mean easier access to stronger doses without jumping through insurance hoops—but the steep out-of-pocket cost ($500/month) keeps it out of reach for many. It’s a mixed bag: more convenience for some, yet another example of how pricey these buzzy meds remain.
AP-NORC poll: Many say Medicaid, food stamps underfunded amid GOP cuts push
negativeHealth
A fresh AP-NORC poll reveals that a majority of Americans believe programs like Medicaid and food stamps aren’t getting enough funding—contrary to the GOP’s push to slash spending on these safety nets. In short, the public isn’t buying the argument that these programs are overfunded.
Editor’s Note: This isn’t just another partisan spat—it highlights a clear disconnect between what lawmakers are prioritizing and what voters actually want. With rising living costs and economic uncertainty, cuts to these programs could hit vulnerable households hard, and the poll suggests the political backlash might be sharper than some in Congress expect.
This mother relies on SNAP to help feed her kids. Now, she's bracing for cuts
negativeHealth
A mom who depends on SNAP (the federal food assistance program) to put meals on the table for her kids is worried about upcoming changes that could slash benefits for millions. The program might tighten rules on what groceries can be bought, reduce monthly funds, or even kick some families off entirely—leaving many unsure how they'll manage.
Editor’s Note: SNAP isn’t just a policy debate—it’s a lifeline for real families. If benefits shrink, more parents will face impossible choices between rent, medicine, or feeding their kids. This isn’t just about budgets; it’s about hunger creeping back into households that were barely staying afloat.
Health Care Roundup: Market Talk
neutralHealth
This piece dives into the latest chatter around health care stocks, spotlighting companies like Regis Healthcare and CSPC Pharmaceutical. Think of it as a quick pulse check on how these players are faring in the market—whether they’re catching investor interest or facing headwinds.
Editor’s Note: For anyone keeping tabs on health care investments, this roundup offers a snapshot of which companies are making waves (or ripples) in the sector. It’s not about groundbreaking news, but more like catching up on the watercooler talk of the financial world—useful for investors or anyone curious about where health care money is flowing.

Why World Pulse Now?

Global Coverage

All major sources, one page

Emotional Lens

Feel the mood behind headlines

Trending Topics

Know what’s trending, globally

Read Less, Know More

Get summaries. Save time

Stay informed, save time
Learn more

Live Stats

Articles Processed

8,570

Trending Topics

126

Sources Monitored

211

Last Updated

19 minutes ago

Live data processing
How it works

Mobile App

Get instant summaries, explore trending stories, and dive deeper into the headlines — all in one sleek, noise-free mobile experience.

Get it on Google PlayDownload on the App Store
Coming soon on iOS and Android.

1-Minute Daily Briefing

Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more

By subscribing, you agree to our Privacy Policy